News Conference News AHA 2025 Artificial Intelligence Successfully Adjudicates Clinical Events in CV Trials Yael L. Maxwell November 13, 2025
News Conference News ESC 2022 Only Very Small Risk of Muscle Symptoms With Statins: CTT Collaboration Michael O'Riordan August 29, 2022
News Conference News The Structural Heart Disease Summit 2018 High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense? Michael O'Riordan June 22, 2018
News Conference News TCT 2017 Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock Yael L. Maxwell November 09, 2017
News Conference News EAS 2017 EAS Consensus Document Strives to Banish Skepticism Over LDL Cholesterol’s Causal Role in Atherosclerosis Yael L. Maxwell April 24, 2017
News Conference News AHA 2016 Racial Differences in How Patients Perceive CVD Risk Should Spur Rethink in Management Yael L. Maxwell November 16, 2016